Shirasawa M, Yoshida T, Shimoda Y, Takayanagi D, et al. Differential Immune-Related Microenvironment Determines PD-1/PD-L1 Blockade Efficacy in Advanced Non-Small Cell Lung Cancer Patients. J Thorac Oncol 2021 Aug 19. pii: S1556-0864(21)02373.
PMID: 34419685